A perfect key to success by these HD0-200 real questions

If you really to show your professionalism so just Passing the HD0-200 exam is not sufficient. You should have enough HDI Qualified Help Desk Senior Analyst knowledge that will help you work in real world scenarios. Killexams.com specially focus to improve your knowledge about HD0-200 objectives so that you not only pass the exam, but really get ready to work in practical environment as a professional.

Exam Code: HD0-200 Practice test 2022 by Killexams.com team
HDI Qualified Help Desk Senior Analyst
HDI Qualified mock
Killexams : HDI Qualified mock - BingNews https://killexams.com/pass4sure/exam-detail/HD0-200 Search results Killexams : HDI Qualified mock - BingNews https://killexams.com/pass4sure/exam-detail/HD0-200 https://killexams.com/exam_list/HDI Killexams : HDI rebrands as ADENTRA No result found, try new keyword!LANGLEY, B.C. -- Hardwoods Distribution Inc. (HDI) has rebranded the company to ADENTRA Inc. and launched a new website: ADENTRAgroup.com. In November, the company announced its plans to rebrand ... Tue, 06 Dec 2022 04:13:00 -0600 en-US text/html https://www.woodworkingnetwork.com/news/woodworking-industry-news/hdi-rebrands-adentra Killexams : Hardwoods Distribution's (TSE:HDI) Shareholders Will Receive A Bigger Dividend Than Last Year

Hardwoods Distribution Inc.'s (TSE:HDI) dividend will be increasing from last year's payment of the same period to $0.13 on 27th of January. This takes the annual payment to 1.7% of the current stock price, which unfortunately is below what the industry is paying.

See our latest analysis for Hardwoods Distribution

Hardwoods Distribution's Payment Has Solid Earnings Coverage

Even a low dividend yield can be attractive if it is sustained for years on end. However, Hardwoods Distribution's earnings easily cover the dividend. This means that most of what the business earns is being used to help it grow.

Over the next year, EPS is forecast to fall by 37.1%. Assuming the dividend continues along latest trends, we believe the payout ratio could be 13%, which we are pretty comfortable with and we think is feasible on an earnings basis.

historic-dividend

Hardwoods Distribution Has A Solid Track Record

The company has an extended history of paying stable dividends. Since 2012, the dividend has gone from $0.0798 total annually to $0.346. This means that it has been growing its distributions at 16% per annum over that time. It is good to see that there has been strong dividend growth, and that there haven't been any cuts for a long time.

The Dividend Looks Likely To Grow

The company's investors will be pleased to have been receiving dividend income for some time. Hardwoods Distribution has seen EPS rising for the last five years, at 40% per annum. Earnings have been growing rapidly, and with a low payout ratio we think that the company could turn out to be a great dividend stock.

We Really Like Hardwoods Distribution's Dividend

Overall, we think this could be an attractive income stock, and it is only getting better by paying a higher dividend this year. The earnings easily cover the company's distributions, and the company is generating plenty of cash. If earnings do fall over the next 12 months, the dividend could be buffeted a little bit, but we don't think it should cause too much of a problem in the long term. Taking this all into consideration, this looks like it could be a good dividend opportunity.

Investors generally tend to favour companies with a consistent, stable dividend policy as opposed to those operating an irregular one. However, there are other things to consider for investors when analysing stock performance. For example, we've identified 3 warning signs for Hardwoods Distribution (2 are significant!) that you should be aware of before investing. Looking for more high-yielding dividend ideas? Try our collection of strong dividend payers.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here

Sat, 12 Nov 2022 22:41:00 -0600 en-US text/html https://finance.yahoo.com/news/hardwoods-distributions-tse-hdi-shareholders-123412588.html
Killexams : QOL Up With Pembrolizumab Versus Ipilimumab, HDI in Resected Melanoma

MONDAY, Nov. 28, 2022 (HealthDay News) -- For patients with high-risk resected melanoma, adjuvant pembrolizumab improves quality of life (QOL) compared with standard of care with ipilimumab or high-dose interferon α 2b (HDI), according to a study published online Nov. 23 in JAMA Oncology.

Joseph M. Unger, Ph.D., from the Fred Hutchinson Cancer Center in Seattle, and colleagues compared QOL in patients with resected melanoma at high risk for relapse who were treated with adjuvant pembrolizumab or standard of care. A total of 832 patients from the S1404 phase 3 randomized clinical trial were included and were evaluable for the primary QOL end point at cycle 3.

The researchers found that the adjusted Functional Assessment of Cancer Therapy (FACT) Biological Response Modifiers (FACT-BRM) trial outcome index (TOI) score at cycle 3 was 9.6 points higher for pembrolizumab versus ipilimumab/HDI, which exceeded the prespecified clinically meaningful difference. Differences by arm exceeded 5 points in favor of pembrolizumab in linear-mixed models through cycle 7. FACT-BRM TOI scores favored the pembrolizumab arm compared with the subset of patients receiving ipilimumab or HDI (differences, 6.0 and 17.0 points, respectively) in post-hoc analyses.

"Physicians should be encouraged to incorporate and discuss treatment-related QOL issues with patients when making shared decisions regarding the risks and benefits of adjuvant therapy in resected melanoma," the authors write.

Several authors disclosed financial ties to pharmaceutical companies, including Merck, which manufactures pembrolizumab and partially funded the study.

Mon, 28 Nov 2022 03:55:00 -0600 en text/html https://roanoke.com/lifestyles/health-med-fit/qol-up-with-pembrolizumab-versus-ipilimumab-hdi-in-resected-melanoma/article_e1fa28d4-cf62-5d96-bf8b-1979b5018538.html
Killexams : HDI Announces Third Quarter 2022 Results

Quarterly Dividend Increase of 8%

LANGLEY, BC, Nov. 8, 2022 /CNW/ - Hardwoods Distribution Inc. ("HDI" or the "Company") today announced financial results for the three and nine months ended September 30, 2022 and an 8% increase to the quarterly dividend. HDI is one of North America's largest suppliers of specialty building products to fabricators, home centers and professionals dealers servicing the repair and remodel, residential, and commercial construction end-markets. The Company currently operates a network of 86 facilities in the United States and Canada. All amounts are shown in United States dollars ("U.S. $" or "$"), unless otherwise noted.

Third Quarter Highlights

  • Third quarter sales grew 39.9% to $659.7 million, a year-over-year increase of $188.0 million. Achieved organic sales growth of 10.4% and acquisition-based sales growth of 29.9%.
  • Gross profit climbed 19.6%, or $22.8 million, to $139.0 million, with gross profit margin percentage of 21.1%, as compared to 24.6% in the same period last year.
  • Profit per share was $1.28; adjusted profit per share was $1.32 per share
  • Adjusted EBITDA climbed 3.4% to $66.0 million, from $63.8 million during the same period in 2021.
  • Cash flow from operating activities, before changes in working capital, was $1.84 per share.
  • In Canadian dollars, sales for the third quarter were C$856.7 million, adjusted profit per share was C$1.71, and Adjusted EBITDA was C$85.7 million.
  • The board of directors today approved an 8% increase to the quarterly dividend to C$0.13 per share, from C$0.12 per share previously, which equates to C$0.52 per share on an annual basis. The increase is effective with the quarterly dividend payable on January 27, 2023 to shareholders of record as at January 16, 2023.

"We achieved another quarter of excellent financial and operating performance as our growth strategy, proven business model and disciplined operating management combined to deliver very strong third quarter results," said Rob Brown, HDI's President and CEO. "Market conditions remained supportive of our business, with increased product prices resulting in strong organic sales growth of over 10% as compared to the same quarter last year. Combined with acquisition-based growth, our total sales grew nearly 40% year-over-year."

"Our results reflect the positive impact of our new Mid-Am and Novo operations, acquired in Q3 2021 and Q1 2022, respectively. These businesses have brought us important scale, access to new geographies, and a strong presence in the U.S. Pro Dealer and home center channels, and combined, are expected to deliver over $1 billion in pro forma sales in 2022."

"Importantly, our performance has enabled us to increase our returns to investors. In the first nine months of 2022, we returned almost $25 million to shareholders through a combination of dividends and share repurchases, up from $5.0 million in the same period last year. With today's announcement of an 8% increase to our quarterly dividend, we are providing further returns to our shareholders going forward."

"Going forward, we will continue to closely monitor economic conditions and the impacts that price inflation, rising interest rates, and other factors can have on our business. We benefit from a highly experienced team with a long track record of successfully managing our operations and controlling costs through changing markets. We believe our business has the resilience to manage through these cycles, and we anticipate a multi-year runway for growth and value creation as we benefit from our leading market position and the long-term positive fundamentals underpinning the North American building products market," said Mr. Brown.

Outlook

In the nearer term we anticipate that rising inflation and latest interest rate hikes will have a negative impact on economic activity, and this may result in a moderation of demand for our products. As we have demonstrated in previous cycles, we will take all necessary actions required to effectively manage our business and cash flows. We maintain a strong balance sheet which provides financial stability through periods of changing market conditions. Our business model also converts a high proportion of EBITDA to operating cash flow before changes in working capital, and during periods of reduced activity our investment in working capital has historically decreased, resulting in an additional source of cash.

Over the long term we expect demand for our products to remain robust, supported by strong fundamentals in our end markets. We continue to see a multi-year runway for growth in the repair and remodel, residential, and commercial end-markets that we participate in.

Outlook for our end-markets

The repair and remodel market (~40% of sales) is expected to remain strong, albeit with a tempering of the higher-than-normal growth rates experienced in the past year. The Joint Center for Housing Studies of Harvard University anticipates a growth rate of 6.5% for the U.S. repair and remodel market by the third quarter of 2023. Overall, the market remains well supported by record levels of home equity in the U.S. and a median home age of over 40 years. Disaster repairs and mitigation projects following Hurricane Ian are also expected to support the home remodeling market in the coming year.

In the residential construction market (~40% of sales), new building starts have moderated as affordability headwinds weigh on consumers, but remain at historically healthy levels. Given that housing completions have not kept pace with starts over the past quarters, we also continue to see an elongated demand curve for our products, which are typically installed during the finishing stages of home construction. Over the longer term, leading indicators for the residential construction market remain highly favorable. Housing starts have meaningfully lagged population growth this past decade, and it is estimated that the U.S. has a housing supply deficit of over 3.5 million units. This supply deficit, combined with positive demographic factors, is expected to underpin long-term demand for new housing.

The demand outlook for U.S. commercial markets (~15% of sales) is mixed, with some sectors showing strength and others recovering at a slower pace. Commercial market participation is highly diverse for HDI and includes construction activity in healthcare, education, public buildings, hospitality, office, retail facilities and recreational vehicles. We expect certain of these commercial end markets will perform better than others, with the broad nature of our participation reducing the impact of dynamics in any one geography or end market.

Q3 2022 Investor Call

HDI will hold an investor call on Wednesday November 9, 2022 at 8:00 am Pacific (11:00 am Eastern). Participants should dial 1-888-254-3590 or (647) 484-0475 (GTA) at least five minutes before the call begins. A replay will be available through November 16, 2022 by calling toll free 1-888-390-0541 or (416) 764-8677 (GTA), followed by passcode 852499.

Summary of Results











Three months


Three months


Nine months


Nine months



ended
September 30


ended
September 30


ended
September 30


ended
September 30



2022


2021


2022


2021


Total sales

$ 659,685


$ 471,673


$ 2,004,834


$ 1,100,846


Sales in the US

610,360


426,738


1,847,481


970,393


Sales in Canada (C$)

64,496


56,660


201,853


163,535


Gross profit

138,964


116,190


440,575


250,020


Gross profit %

21.1 %


24.6 %


22.0 %


22.7 %


Operating expenses

(90,902)


(67,303)


(268,549)


(148,160)


Profit from operating activities

$ 48,062


$ 48,887


$ 172,026


$ 101,860


Add: Depreciation and amortization

16,830


11,748


48,523


24,063


Earnings before interest, taxes, depreciation and









amortization ("EBITDA")

$ 64,892


$ 60,635


$ 220,549


$ 125,923


EBITDA as a % of revenue

9.8 %


12.9 %


11.0 %


11.4 %


Add (deduct):









Depreciation and amortization

(16,830)


(11,748)


(48,523)


(24,063)


Net finance income (expense)

(8,926)


(3,803)


(20,097)


(6,664)


Income tax expense

(9,260)


(11,387)


(36,650)


(24,196)


Profit for the period

$ 29,876


$ 33,696


$ 115,279


$ 71,000


Basic profit per share

$ 1.28


$ 1.58


$ 4.89


$3.34


Diluted profit per share

$ 1.27


$ 1.56


$ 4.85


$3.29


Average Canadian dollar exchange rate for one US dollar

$ 0.77


$ 0.79


$ 0.78


0.799


Analysis of Specific Items Affecting Comparability (in thousands of Canadian dollars)


Three months


Three months


Nine months


Nine months



ended
September 30


ended
September 30


ended
September 30


ended
September 30



2022


2021


2022


2021


Earnings before interest, taxes, depreciation and









amortization ("EBITDA"), per table above

$ 64,892


$ 60,635


$ 220,549


$ 125,923


Non-cash LTIP expense

1,075


1,288


2,927


3,576


Transaction expenses


1,903


892


4,071


Adjusted EBITDA

$ 65,967


$ 63,826


$ 224,368


$ 133,570


Adjusted EBITDA as a % of revenue

10.0 %


13.5 %


11.2 %


12.1 %











Profit for the period, as reported

$ 29,876


$ 33,696


$ 115,279


$ 71,000


Adjustments, net of tax

957


2,579


3,256


6,310


Adjusted profit for the period

$ 30,833


$ 36,275


$ 118,535


$ 77,310











Basic profit per share, as reported

$ 1.28


$ 1.58


$ 4.89


$ 3.34


Net impact of above items per share

0.04


0.12


0.14


0.30


Adjusted basic profit per share

$ 1.32


$ 1.70


$ 5.03


$ 3.64











Diluted profit per share, as reported

$ 1.27


$ 1.56


$ 4.85


$ 3.29


Net impact of above items per share

0.04


0.12


0.14


0.29


Adjusted diluted profit per share

$ 1.31


$ 1.68


$ 4.99


$ 3.58



Results from Operations - Three Months Ended September 30, 2022

For the three months ended September 30, 2022, consolidated sales grew to $659.7 million, an increase of $188.0 million, or 39.9%, from $471.7 million in the same period in 2021. Organic sales growth accounted for $48.9 million of this gain, representing a 10.4% increase in consolidated sales. Acquired businesses (the "Acquired Businesses") contributed an additional $140.9 million of the sales growth, and included Novo's July 2022 revenue of $58.8 million and Mid-Am's Q3 2022 revenue of $82.0 million. Combined, additional revenue from Acquired Businesses represented a 29.9% increase in total sales. These gains were partially offset by $1.8 million of unfavorable foreign exchange impact.

Third quarter sales from our U.S. operations grew to $610.4 million, an increase of $183.6 million, or 43.0%, from $426.7 million in the same period in 2021. Organic sales growth accounted for $42.7 million of this improvement, representing a 10.0% increase in U.S. sales. The strong organic growth was primarily supported by increased product prices, partially offset by a modest decrease in volumes. Incremental revenue from Acquired Businesses contributed an additional $140.9 million to third quarter U.S. sales growth, representing a 33% increase in U.S. sales.

In Canada, third quarter sales increased by C$7.8 million, or 13.8%, compared to the same period in 2021. The Canadian sales growth was entirely organic and reflects higher product prices year-over-year, partially offset by a modest decrease in volumes.

Gross profit for the third quarter grew 19.6% to $139.0 million, from $116.2 million in the same quarter last year. This $22.8 million improvement reflects the significant sales growth, partially offset by a lower gross margin percentage. At 21.1%, our gross margin percentage did not match the unusually high 24.6% achieved in Q3 2021 when favorable market dynamics, including strong demand and tight supply, resulted in a rapid increase in product prices as compared to the cost of inventory.

For the three months ended September 30, 2022, operating expenses increased by $23.6 million to $90.9 million, from $67.3 million in Q3 2021. As a percentage of sales, operating expenses were lower at 13.8%, as compared to 14.3% in the same period last year.

The $23.6 million increase in operating expenses includes $15.8 million related to incremental operating expenses from our Acquired Businesses, $6.4 million to support organic growth, and $3.3 million of amortization on intangible assets acquired in connection with the Novo and Mid-Am acquisitions. These increases were partially offset by $1.9 million of Novo-related transaction costs incurred in Q3 2021, which did not repeat in 2022.

For the three months ended September 30, 2022, depreciation and amortization increased to $16.8 million, from $11.7 million in Q3 2021. This $5.1 million increase primarily relates to the acquisition and operations of the Novo and Mid-Am businesses and is comprised of $3.3 million of amortization on acquired intangible assets and $1.8 million from depreciation related to operations.

For the three months ended September 30, 2022, net finance expense increased to $8.9 million, from $3.8 million last year. This increase was primarily driven by interest costs on the additional bank indebtedness used to finance the acquisitions of Novo and Mid-Am, as well as higher interest rates.

For the three months ended September 30, 2022, income tax expense decreased to $9.3 million, from $11.4 million last year, primarily reflecting lower taxable income.

Third quarter Adjusted EBITDA climbed 3.4% to $66.0 million, from $63.8 million during the same period in 2021. The $2.2 million improvement was driven primarily by the $22.8 million increase in gross profit, partially offset by the $20.6 million increase in operating expenses (before changes in depreciation and amortization, non-cash LTIP expense, and transaction expenses).

Profit for the third quarter decreased by 11.3% to $29.9 million, from $33.7 million in Q3 2021. The $3.8 million change primarily reflects a $5.1 million increase in depreciation and amortization, and the $5.0 million increase in net finance expense, partially offset by the $4.3 million increase in EBITDA and $2.1 million lower income tax expense.

For the three months ended September 30, 2022, we generated basic profit per share of $1.28, as compared to $1.58 in Q3 2021, a decrease of 19.0%. Adjusted profit was $30.8 million, as compared to $36.3 million in Q3 2021, a decrease of 15.0% and Adjusted diluted profit per share was $1.31, as compared to $1.68, a decrease of 22.0%.

Results from Operations - Nine Months Ended September 30, 2022

For the nine months ended September 30, 2022, consolidated sales climbed 82.1% to $2.0 billion, an increase of $904.0 million from $1.1 billion in the same period in 2021. Organic sales growth accounted for $241.9 million of this gain, representing a 22.0% increase in consolidated sales. Acquisition-based revenue growth, including Novo's January to July 2022 revenue of $453.5 million, and Mid-Am's year-to-date revenue of $219.0 million, increased consolidated revenue by a combined 61.1% year-over-year. These gains were partially offset by the first quarter 2021 divestiture of our HMI business, which resulted in $6.4 million of sales not recurring in the current period. Foreign exchange fluctuations in the Canadian dollar also had an unfavorable $4.0 million impact on sales results.

First nine months sales from our U.S. operations grew 90.4% to $1.8 billion, a year-over-year increase of $877.1 million, from $970.4 million in the same period last year. Organic sales growth accounted for $204.6 million of this improvement, representing a 21.1% year-over-year increase in U.S. sales. The strong organic growth was primarily supported by robust market demand, particularly during the first half of the year, which in turn contributed to improved product prices. The Novo and Mid-Am operations contributed an additional $672.5 million to year-to-date U.S. sales growth, representing a 69.3% increase in U.S. sales.

In Canada, sales for the first nine months increased by C$38.3 million, or 23.4%, compared to the same period in 2021. The Canadian sales growth was entirely organic and reflects the strong market demand particularly in the first half of the year, which resulted in improved market prices for our products year-over-year.

Gross profit for the first nine months grew 76.2% to $440.6 million, from $250.0 million in the same period last year. This $190.6 million improvement reflects our significant organic and acquisition-based sales growth. At 22.0%, our gross profit margin was slightly lower than the 22.7% we achieved in the same period last year. The gross margin percentage in 2021 was temporarily elevated due to favorable market dynamics, including strong demand and tight supply.

For the nine months ended September 30, 2022, operating expenses were $268.5 million as compared to $148.2 million in the same period last year, an increase of $120.4 million. As a percentage of sales, operating expenses were well controlled at 13.4%, similar to 13.5% in the first nine months of last year.

The $120.4 million increase in operating expenses includes $90.3 million related to operation of our Acquired Businesses, $21.0 million to support organic growth, and $12.3 million of amortization on intangible assets acquired in connection with the Novo and Mid-Am acquisitions. These increases were partially offset by $3.2 million of Novo-related transaction costs incurred in the first nine months of 2021, which did not repeat in the 2022 period.

For the nine months ended September 30, 2022, depreciation and amortization increased by $24.5 million to $48.5 million, from $24.1 million in the prior-year period. This increase mainly relates to the acquisition and operations of the Novo and Mid-Am businesses and is primarily comprised of $12.3 million of amortization on acquired intangible assets, and $12.1 million from depreciation related to operations.

For the nine months ended September 30, 2022, net finance expense increased to $20.1 million, from $6.7 million last year. The increase was primarily driven by interest on issuance of new bank indebtedness used to finance the acquisitions of Novo and Mid-Am, combined with higher interest rates.

For the nine months ended September 30, 2022, income tax expense increased to $36.7 million, from $24.2 million last year, primarily driven by a higher taxable income.

Year-to-date Adjusted EBITDA climbed 68.0% to $224.4 million, from $133.6 million in the same period of 2021. This $90.8 million improvement reflects the $190.6 million increase in gross profit, partially offset by the $99.8 million increase in operating expenses (before changes in depreciation and amortization, non-cash LTIP expense, and transaction expenses).

Profit for the first nine months grew 62.4% to $115.3 million, from $71.0 million in the first nine months of 2021. The $44.3 million profit improvement primarily reflects the $94.6 million increase in EBITDA, partially offset by a $24.5 million increase in depreciation and amortization, the $12.5 million increase in income tax expense, and the $13.4 million increase in net finance expense.

For the nine months ended September 30, 2022, basic profit per share climbed 46.4% to $4.89, from $3.34 in the same period last year. Adjusted profit increased 53.3% to $118.5 million, from $77.3 million in the first nine months of 2021 and Adjusted diluted profit per share grew 39.4% to $4.99, from $3.58 in the same period last year.

About HDI

HDI is one of North America's largest suppliers of specialty building products to fabricators, home centers and professional dealers servicing the new residential, repair and remodel, and commercial construction end-markets. The Company currently operates a network in North America of 86 facilities in the United States and Canada. HDI's common shares are listed on the Toronto Stock Exchange under the symbol HDI.

Non-GAAP Measures - EBITDA

References to "EBITDA" are to earnings before interest, income taxes, depreciation and amortization, where interest is defined as net finance costs as per the consolidated statement of comprehensive income. Furthermore, this press release references certain EBITDA Ratios, such as EBITDA margin (being EBITDA as a percentage of revenues). In addition to profit, HDI considers EBITDA and EBITDA Ratios to be useful supplemental measures of the Company's ability to meet debt service and capital expenditure requirements, and interprets trends in EBITDA and EBITDA Ratios as an indicator of relative operating performance.

References to "Adjusted EBITDA" are EBITDA as defined above, before certain items related to business acquisition activities. "Adjusted EBITDA margin" is as defined above, before certain items related to business acquisition activities, mark-to-market adjustments, and revaluation of deferred tax assets. References to "Adjusted profit", "Adjusted basic profit per share", and "Adjusted diluted profit per share" are profit for the period, basic profit per share, and diluted profit per share, before certain items related to business acquisition activities, mark-to-market adjustments, and revaluation of deferred tax assets. The aforementioned adjusted measures are collectively referenced as "the Adjusted Measures". HDI considers the Adjusted Measures to be useful supplemental measures of the Company's profitability, its ability to meet debt service and capital expenditure requirements, and as an indicator of relative operating performance, before considering the impact of business acquisition activities.

EBITDA, EBITDA Ratios, and the Adjusted Measures (collectively "the Non-GAAP Measures") are not measures recognized by International Financial Reporting Standards ("IFRS") and do not have a standardized meaning prescribed by IFRS. Investors are cautioned that the Non-GAAP Measures should not replace profit, earnings per share or cash flows (as determined in accordance with IFRS) as an indicator of our performance. HDI's method of calculating the Non-GAAP Measures may differ from the methods used by other issuers. Therefore, Non-GAAP Measures may not be comparable to similar measures presented by other issuers.

Forward-Looking Statements

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING INFORMATION

This news release includes forward-looking statements. These involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements or industry results to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are identified by the use of terms and phrases such as "anticipate", "believe", "estimate", "expect", "may", "plan", "will", and similar terms and phrases, including references to assumptions. Forward-looking information is included, but not limited to, information included under the headings "Second Quarter Highlights", "Outlook", "Results of Operations for the Three Months Ended September 30, 2022", and "Results of Operations for the Nine Months Ended September 30, 2022."

These forward-looking statements reflect current expectations of management regarding future events and operating performance as of the date of this news release. Forward-looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved. A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements, including, but not limited to: it is difficult to reliably measure the potential impact of this uncertainty caused by the COVID-19 pandemic on our future financial results and the impacts to our Company are not determinable at the date of these financial statements, however they could be material and include impairments of receivables, inventory and reduction in available liquidity; given the uncertainty around the potential impact of COVID-19, this may impact our estimates disclosed in the consolidated financial statements given that there is significant judgment and estimation uncertainty; our results are dependent upon the general state of the economy and downturns in the economy (including inflation and rising interest rates), natural disasters, disease outbreaks, terrorist activities, or threats or acts of armed conflict (including the conflict between Russia and Ukraine), could have a negative impact on our business, financial condition, and results of operations; decreases in the supply of, demand for, or market values of our products could harm our business; our products may be subject to negative trade outcomes; we may not be able to sustain our level of sales or EBITDA margins; competition in our markets may lead to reduced revenues and profitability; we may become subject to more stringent regulations; we are dependent upon our management information systems; our insurance may be insufficient to cover losses that may occur as a result of our operations; we are dependent upon the financial condition and results of operations of our business; our credit facilities affect our liquidity, contain restrictions on our ability to borrow funds, and impose restrictions on distributions that can be made by our operating limited partnerships; and, other risks described in our Annual Information Form our Information Circular and in the MD&A.

Although the forward-looking statements contained in this news release are based upon what management believes to be reasonable assumptions, management cannot assure investors that actual results will be consistent with these forward-looking statements. The forward-looking statements reflect management's current beliefs and are based on information currently available.

All forward-looking information in this news release is qualified in its entirety by this cautionary statement and, except as may be required by law, HDI undertakes no obligation to revise or update any forward-looking information as a result of new information, future events or otherwise after the date hereof.

SOURCE Hardwoods Distribution Inc.

Cision View original content: http://www.newswire.ca/en/releases/archive/November2022/08/c0391.html

Mon, 07 Nov 2022 10:00:00 -0600 text/html https://stockhouse.com/news/press-releases/2022/11/08/hdi-announces-third-quarter-2022-results
Killexams : HDI Global Specialty selects Sapiens for complete P&C core transformation

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

Wed, 23 Nov 2022 04:34:00 -0600 en text/html https://seekingalpha.com/news/3911113-hdi-global-specialty-selects-sapiens-for-complete-pc-core-transformation
Killexams : Qualified vs. Non-Qualified Dividends: What's the Difference?

qualified vs nonqualified dividends

Many people wonder whether they should be investing in qualified or non-qualified dividends and what the differences are. The largest difference is in how each is taxed. To help you determine what stock paying dividends could have a place in your individual portfolio, you should examine the company’s financial statements, dividend yield, prospects for the future and your own risk tolerance. You also determine if the dividends are regular dividends or qualifying dividends. That makes a significant difference in what stocks you invest in due to differences in taxation. A financial advisor can help you find the best dividends for your portfolio and even manage your assets on your behalf.

What Is Dividend Income? 

Dividend income is part of the income stream from common stocks and it comes from a portion of the profits of a company, paid to shareholders on a regular basis. The remainder of the profits after dividends are paid out is reinvested in the firm. Not every company pays dividends to shareholders. Dividend income is especially important in times of declining stock markets since investing for value is often a more intelligent strategy than investing for growth.

Stocks with a substantial dividend yield are usually not rapidly growing. They are considered value stocks. Value investing is often an important strategy during a recession or a bear market. Dividend income is taxed. When you explore qualified vs. non-qualified dividends, you will discover the differences in taxation of distinct types of dividends.

Qualified Dividends

qualified vs nonqualified dividends

If the dividends you receive are classified as qualified dividends, you pay taxes on them at the capital gains rate. The capital gains rate is often lower than the tax rate on non-qualified or ordinary dividends. If you are a lower-income individual, you may have to pay no tax to the federal government on the portion of your dividends that are classified as qualified dividends.

If you receive qualified dividend income, the capital gains tax rate is 20 percent, 15 percent or 0 percent depending on your income. It is often more profitable to receive qualified dividends than ordinary dividends. Dividends must meet these criteria to be considered qualified dividends:

  • The dividend must be paid by a U.S. company or a qualifying foreign company.

  • If you purchase stock on or before the ex-dividend date and then hold it for at least 61 days before the next dividend is paid, then the dividend is a qualified dividend.

  • The stock must meet the holding period. For dividends to be taxed at the capital gains rate, the holding period may be 60 days for mutual funds and common stock and 90 days for preferred stock. If you don’t meet the holding period, the dividend will not be qualified.

  • The dividends are not listed with the Internal Revenue Service (IRS) as those that don’t qualify for preferential status.

  • Dividends must not be capital gains distributions or payments from tax-exempt organizations.

Ordinary (Non-Qualified) Dividends

Most dividends paid by a corporation are ordinary dividends and do not conform to the criteria for qualified dividends. This means they are taxed at your individual marginal income tax rate. The marginal tax rate is the income tax rate paid on the last dollar of income earned by the investor. In almost every circumstance, qualified dividends are better for the investor than ordinary dividends.

If your tax bracket is more than 15 percent but less than the top tax bracket of 37 percent, you pay 15 percent on qualified dividends. If your tax bracket is 37 percent, you pay 20 percent on qualified dividends. This is significant when comparing ordinary dividends and qualifying dividends. A general rule that will save money is to hold investments paying ordinary dividends in tax-advantaged accounts like traditional Individual Retirement Accounts (IRA). Qualified dividends can be held in taxable accounts since the tax rate is likely lower.

The Internal Revenue Service (IRS) advises that taxpayers assume that any dividend paid on common or preferred stock is an ordinary dividend unless the issuing corporation or other body advises you differently. Businesses that almost always issue ordinary dividends rather than qualified dividends include the following:

Dividend Reinvestment Plans (DRIPs) and payments in lieu of dividends are also taxed at a higher rate. Dividends will be reported to you on IRS Form 1099-DIV and specified as either ordinary or qualified dividends.

The Bottom Line

qualified vs nonqualified dividends

Dividend income is a valuable part of your return from stock investing. If you are an income, or value, investor, you usually choose stocks with higher dividend yields. Capital gains income, which comes from an increase in stock price, is important in a rising market, but dividend income takes the lead during a recessionary economy. Most dividends are ordinary dividends that are taxed at an investor’s marginal tax rate. Ordinary dividends should be held in a tax-advantaged account if possible.

Tips on Investing

  • It isn’t always straightforward to determine the types of investments that you should be making. It can be wise to get professional advice from a financial advisor when investing to help you find the right mix of assets. If you don’t have a financial advisor, finding one doesn’t have to be hard. SmartAsset’s free tool can help you find a compatible financial advisor who can not only help you choose stocks based on your preferences but who can deal with the tax implications of qualified vs non-qualified dividends. You can choose between three qualified financial advisors in your local area. If you are ready, get started now.

  • Not only can a financial advisor help you with your dividend income, but no matter what the market conditions are, an advisor can help you choose investments with an adequate return based on your risk preferences. Find out how much a financial advisor may cost using SmartAsset’s free tool.

Photo credit: ©iStock.com/fizkes, ©iStock.com/Jirapong Manustrong, ©iStock.com/Orientfootage

The post Qualified vs. Non-Qualified Dividends appeared first on SmartAsset Blog.

Mon, 05 Dec 2022 00:33:00 -0600 en-US text/html https://www.yahoo.com/entertainment/qualified-vs-non-qualified-dividends-140023746.html
Killexams : Evan Mock Is Having the Best Time

On a latest afternoon, Evan Mock was trying to do laundry in his East Village condo, but something was wrong with the dryer. Perturbed beeps cut through the retro-soul music playing in the airy third-floor walk-up. The machine kept starting and stopping. He mentioned a theory, something about excessive lint accumulation and a defective filter.

Mr. Mock, 25, is probably best known for his role as the pink-haired, Park Avenue-raised, Tarkovsky-loving bisexual son of a right-wing media mogul on the HBO Max reboot of “Gossip Girl,” which returns for its second season on Dec. 1. But the downtown denizen has a lot of other things going on.

A king of the “collab,” he has worked with brands including the Danish jewelry manufacturer Pandora and the Italian footwear designer Giuseppe Zanotti. He has modeled for designers including Paco Rabanne and Virgil Abloh. His skateboarding prowess has landed him a hefty sponsorship from Hurley and an elusive spot on the Instagram grid of Frank Ocean. A few months ago he started a fashion line, Wahine, with the stylist Donté McGuine.

He is a bona fide multi-hyphenate, a party-circuit fixture, an it boy, a man about town. Also, he has frosted tips now.

Despite the hyper résumé, Mr. Mock is laid-back. Serene. As the light streamed into his apartment, he reclined by a floor-to-ceiling corner window. “Sometimes it’s too much,” he said, referring to the intense sunlight. “But I’m not complaining.”

He took a swig of coconut water from a Tetra Pak. His feet were up. They were clad in last month’s limited release North Face x Paraboot shoes, the ones with the vulcanized rubber outsoles, matelassé full grain leather uppers and an elastic collar — a mule so exclusive that it was not even available for purchase. As the streetwear website Hypebeast reported: “Simply put, you cannot buy this.”

Growing up, Mr. Mock often went around barefoot. Born and raised on the North Shore of Oahu, his father put him on his first surfboard when he was 2 years old. “I caught my first wave before I could swim,” he said.

He was home-schooled into his teenage years to accommodate peak surf hours. Around age 11, he also got into skateboarding. (“Pretty late,” he said.) By 16, he was making more than $1,500 a month from skateboarding sponsorships. He then moved to California to pursue what he called his “skateboarding dreams.” (He did air quotes around the words “skateboarding dreams.”)

Hints of his modeling career were scattered throughout the tidy two-bedroom, two-bathroom apartment. On his kitchen counter sat a Louis Vuitton purse — a brand for which he walked the runway in 2019. In the corner of the living room, there was an overflowing Rimowa suitcase — the luxury German luggage maker for which he wrote, co-produced and starred in an online commercial last year. It shows Mr. Mock skateboarding through Manhattan donning a Rimowa cross-body messenger bag as he recounts, in a voice-over narrative, a whirlwind romance with a girl he met outside a club in Barcelona. Entranced by her beauty, he speaks of impulsively buying her a ticket to accompany him to Paris. But a lost passport, a brief stint in airport jail and six-hour flight delay put an end to the fling.

Across the room, by a stack of shoe boxes, what looked at first like a regular McDonald’s Happy Meal box, was, upon closer inspection, a box of Cactus Plant Flea Market x McDonald’s collectibles from the streetwear label’s limited-run release. The figurines (originally retailing around $10) were reportedly listed on eBay for over $25,000, though the prices have since dropped significantly.

Mr. Mock got up to clean his lint trap. “Let’s just get on some bikes,” he said.

He puts a lot of mileage on his VanMoof e-bike. The day before, he rode uptown for a “Gossip Girl” A.D.R. (automated dialogue replacement) session, then back down to the Lower East Side to check out a Japanese whiskey bar he might invest in on Chrystie Street.

“We could go to Curbs,” Mr. Mock said, referring to a section of Lafayette Street that has become popular among New York skateboarders for the many curbs afforded by its triangular layout.

He started to get changed, switching his white T-shirt for a vintage dark gray Number Nine T-shirt. Above the chest pocket it had a small graphic of a speech bubble containing the word “cigarettes.” “It’s a Japanese brand that was illest back in the day,” Mr. Mock said of Number Nine. “Everyone in Japan knows what’s up.”

He put on and then took off a hoodie of his own design, a boxy Wahine zip-up. On the front, the outline of a valentine heart surrounding a word that cannot be printed in The New York Times. “I drew it on my friend’s bathroom wall and then I took a picture of it,” he said of the design’s origin.

He completed the outfit with a pair of dark-wash Palace jeans, Ambush edition Nike Air Adjust Force sneakers, a silver bomber jacket, a Palace hat and Isabel Marant sunglasses. Outside, he glided through Alphabet City on his next-gen smart-tech bike. As the scenery swept by, he kept one hand in the pocket of the unzipped bomber.

Near the REI store, he swerved lithely across Houston Street to provide a hello kiss to the photographer Gray Sorrenti, who happened to be passing by with the model-actress Blue Lindeberg. The chance encounter took place directly across from the 55-by-75-foot Calvin Klein billboard where, one year ago, Mr. Mock had appeared, smiling down at NoHo in nothing but black boxer briefs and thigh tattoos.

The next stop was Madhufalla, a juice and smoothie bar on Mulberry Street. Mr. Mock ordered his usual: a ginger shot and a wheatgrass shot. “Sweeter than you’d think,” he said. He downed both in the store and ordered an açai berry almond milk smoothie to go.

Around the corner, at Curbs, he fist-bumped a couple of acquaintances before taking a seat on a bench. Between sips of the smoothie, he talked about “Gossip Girl.” The original CW series, which ran from 2007 through 2012, was, he said, “before my time.” And when the showrunner of the HBO Max reboot, Joshua Safran, reached out to him about playing the part of Aki Menzies, Mr. Mock had never acted.

“There were a lot of different firsts,” he said. “When I first read the script, I thought there was nothing more opposite than my actual life. In terms of living somewhere cold, going to a private school, all the drama.”

He paused. Then picked up again: “It’s funny, because I never actually went to school. But the character is basically me — besides being filthy rich, going to a private school and living uptown in New York.”

On his first day of filming, he had to take part in a sex scene with Emily Alyn Lind, the actress who plays his girlfriend. The inherently awkward situation had the added discomfort of taking place in September 2020. Between shots, the cast members wore K95 masks and plastic face coverings. During their downtime, the actors had to isolate in a room by themselves until they were called back to the set. “But, honestly, I’m kind of glad it happened like that, because we got the weird stuff out of the way,” Mr. Mock said. “Hopefully, everything from here on out will be a little bit quote-unquote normal.”

He watched a skateboarder wipe out in front of the bistro Jack’s Wife Freda. Ms. Lindeberg, the actress and model, walked by again. This is something Mr. Mock loves about New York: “You basically have no option but to see homies everywhere you go,” he said. As if on cue, another friend, the actor Nico Hiraga, rode up on a skateboard, joined shortly by another skateboarding friend, George Hemp.

“We could go play pool,” Mr. Mock suggested.

Soon Mr. Hiraga and Mr. Hemp got Citi Bikes, and the group headed north. All three biked almost exclusively one-handed. The ride was punctuated by more run-ins. On St. Marks Place, Mr. Mock pulled over to hug his brand-deal agent, Jenelle Phillip, who was outdoor-dining at Cafe Mogador. On East 10th Street, at the edge of Tompkins Square Park, he stopped to chat with the skateboarding documentarian Greg Hunt, who was out with his camera, trying to take advantage of the good light. Mr. Mock said he had spotted other familiar faces in the 12-block journey, but he couldn’t pull over for everyone.

It was early evening by the time he and his friends reached the Ace Bar on East Fifth Street. “Meet the Fockers” was playing on the TV screen above the Skee-Ball machine.

“I love this movie,” Mr. Hiraga said, smiling. “I’m in my saga era.”

A few feet from the pool table, a man stood contrapposto, beer in one hand, the other, adamantly on his hip. Mr. Mock said he tends to stand similarly, in a kind of half-akimbo pose. Skateboarders have a certain way of holding themselves — Mr. Mock offered the word “feminine” to describe it, but then agreed that it’s more about fluidity, or a specific grace that comes from being in a constant negotiation with gravity.

He added that he has broken each arm three times. In one spill, he broke four fingers. What happens, he explained, is that you learn how to fall.

“If you watch skaters fall, it looks like Bruce Lee fighting water,” Mr. Mock said. “Falling in the same certain type of way, you get reflexes after a while. You can save yourself most of the time, but sometimes you can’t.”

Is breaking bones scary?

“It just comes with it,” he said. “You expect it.”

He turned back to the pool table, adjusting his Palace jeans, which were more or less held up by a leather belt that he said he had gotten from “some random dude in Rome.”

Wed, 23 Nov 2022 20:01:00 -0600 en text/html https://www.nytimes.com/2022/11/24/style/evan-mock-is-having-the-best-time.html
Killexams : HDI Global Specialty SE Selects Sapiens for Complete P&C Core Transformation

Sapiens IDITSuite will provide a single overview of policies, from issuing proposals, policy documents to payments

HOLON, Israel, Nov. 23, 2022 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced the deployment of its cloud-first P&C platform IDITSuite with the Netherlands branch of HDI Global Specialty SE (HGS), a leading global specialty insurance provider.

Sapiens_Logo

HGS' legacy system has been replaced by the Sapiens solution in order to provide greater automation and standardization, and globally available oversight on policies, risk exposures and data.

"Our previous system was not an ideal fit for our specialty business," said Ralph Beutter, HGS CEO. "Sapiens has given us the ability to quickly and easily create a bespoke system that serves our needs exactly as required."

Following the successful implementation of IDITSuite in the Netherlands, the next HGS business units to be digitally transformed by Sapiens will be Belgium and Denmark. In addition, HGS has chosen to digitally transform its reinsurance system with Sapiens' digital reinsurance platform, a project scheduled to begin in the near future.

"Sapiens has been extremely pleased with the high level of collaboration and partnership with HGS, leading to successful implementation within a short period of time," said Roni Al-Dor, Sapiens president and CEO. "Sapiens IDITSuite is an award-winning Core P&C platform with rich functionality and ease of use and we are happy to partner with HGS on their transformation journey."

Sapiens IDITSuite is a component-based, core software solution comprised of policy, billing and claims solutions. It supports end-to-end core operations and processes for short-term/non-life insurance from inception to renewal and claims.

About HDI Global Specialty (HGS)

HDI Global Specialty SE is a specialty lines insurer. It is owned by HDI Global SE, part of the Talanx Group. HDI Global Specialty's focus is on writing agency and specialty insurance business with operations in 9 locations and access to a global network of more than 175 countries through the HDI Global SE network. HDI Global Specialty also enjoys the same financial strength as HDI Global SE. For more information, visit https://www.hdi.global/redirect/hdi-global-specialty-se/.

About Sapiens

Sapiens International Corporation (NASDAQ and TASE: SPNS) empowers the financial sector, with a focus on insurance, to transform and become digital, innovative, and agile. Backed by more than 40 years of industry expertise, Sapiens offers a complete insurance platform, with pre-integrated, low-code solutions and a cloud-first approach that accelerates customers' digital transformation. Serving over 600 customers in 30 countries, Sapiens offers insurers across property and casualty, workers' compensation and life markets the most comprehensive set of solutions, from core to complementary, including Reinsurance, Financial & Compliance, Data & Analytics, Digital, and Decision Management. For more information visit https://sapiens.com or follow us on LinkedIn.

Media Contact

Tally Kaplan Porat
Director of Corporate Marketing, Sapiens
tally.kaplanporat@sapiens.com

Investor's Contact

Dina Vince
Head of Investor Relations, Sapiens
dina.vince@sapiens.com

 Forward Looking Statements

Certain matters discussed in this press release that are incorporated herein by reference are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that are based on our beliefs, assumptions and expectations, as well as information currently available to us. Such forward-looking statements may be identified by the use of the words "anticipate," "believe," "estimate," "expect," "may," "will," "plan" and similar expressions. Such statements reflect our current views with respect to future events and are subject to pandemic risks and uncertainties. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to: the degree of our success in our plans to leverage our global footprint to grow our sales; the degree of our success in integrating the companies that we have acquired through the implementation of our M&A growth strategy; the lengthy development cycles for our solutions, which may frustrate our ability to realize revenues and/or profits from our potential new solutions; our lengthy and complex sales cycles, which do not always result in the realization of revenues; the degree of our success in retaining our existing customers or competing effectively for greater market share; difficulties in successfully planning and managing changes in the size of our operations; the frequency of the long-term, large, complex projects that we perform that involve complex estimates of project costs and profit margins, which sometimes change mid-stream; the challenges and potential liability that heightened privacy laws and regulations pose to our business; occasional disputes with clients, which may adversely impact our results of operations and our reputation; various intellectual property issues related to our business; potential unanticipated product vulnerabilities or cybersecurity breaches of our or our customers' systems; risks related to the insurance industry in which our clients operate; risks associated with our global sales and operations, such as changes in regulatory requirements, wide-spread viruses and epidemics like the latest novel coronavirus pandemic, which adversely affected our results of operations, or fluctuations in currency exchange rates; and risks related to our principal location in Israel and our status as a Cayman Islands company.

While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed under the heading "Risk Factors" in our most latest Annual Report on Form 20-F, in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot ensure that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, to conform these statements to actual results or to changes in our expectations.

Logo: http://mma.prnewswire.com/media/585787/Sapiens_Logo.jpg

Cision

View original content:https://www.prnewswire.co.uk/news-releases/hdi-global-specialty-se-selects-sapiens-for-complete-pc-core-transformation-301686107.html

Wed, 23 Nov 2022 03:31:00 -0600 en-US text/html https://finance.yahoo.com/news/hdi-global-specialty-se-selects-122000405.html
Killexams : HDI Global Specialty SE Selects Sapiens for Complete P&C Core Transformation

"Sapiens has been extremely pleased with the high level of collaboration and partnership with HGS, leading to successful implementation within a short period of time," said Roni Al-Dor, Sapiens president and CEO. "Sapiens IDITSuite is an award-winning Core P&C platform with rich functionality and ease of use and we are happy to partner with HGS on their transformation journey."

Sapiens IDITSuite is a component-based, core software solution comprised of policy, billing and claims solutions. It supports end-to-end core operations and processes for short-term/non-life insurance from inception to renewal and claims.

About HDI Global Specialty (HGS)

HDI Global Specialty SE is a specialty lines insurer. It is owned by HDI Global SE, part of the Talanx Group. HDI Global Specialty's focus is on writing agency and specialty insurance business with operations in 9 locations and access to a global network of more than 175 countries through the HDI Global SE network. HDI Global Specialty also enjoys the same financial strength as HDI Global SE. For more information, visit https://www.hdi.global/redirect/hdi-global-specialty-se/.

About Sapiens

Sapiens International Corporation (NASDAQ and TASE: SPNS) empowers the financial sector, with a focus on insurance, to transform and become digital, innovative, and agile. Backed by more than 40 years of industry expertise, Sapiens offers a complete insurance platform, with pre-integrated, low-code solutions and a cloud-first approach that accelerates customers' digital transformation. Serving over 600 customers in 30 countries, Sapiens offers insurers across property and casualty, workers' compensation and life markets the most comprehensive set of solutions, from core to complementary, including Reinsurance, Financial & Compliance, Data & Analytics, Digital, and Decision Management. For more information visit https://sapiens.com or follow us on LinkedIn.

 Forward Looking Statements

Certain matters discussed in this press release that are incorporated herein by reference are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that are based on our beliefs, assumptions and expectations, as well as information currently available to us. Such forward-looking statements may be identified by the use of the words "anticipate," "believe," "estimate," "expect," "may," "will," "plan" and similar expressions. Such statements reflect our current views with respect to future events and are subject to pandemic risks and uncertainties. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to: the degree of our success in our plans to leverage our global footprint to grow our sales; the degree of our success in integrating the companies that we have acquired through the implementation of our M&A growth strategy; the lengthy development cycles for our solutions, which may frustrate our ability to realize revenues and/or profits from our potential new solutions; our lengthy and complex sales cycles, which do not always result in the realization of revenues; the degree of our success in retaining our existing customers or competing effectively for greater market share; difficulties in successfully planning and managing changes in the size of our operations; the frequency of the long-term, large, complex projects that we perform that involve complex estimates of project costs and profit margins, which sometimes change mid-stream; the challenges and potential liability that heightened privacy laws and regulations pose to our business; occasional disputes with clients, which may adversely impact our results of operations and our reputation; various intellectual property issues related to our business; potential unanticipated product vulnerabilities or cybersecurity breaches of our or our customers' systems; risks related to the insurance industry in which our clients operate; risks associated with our global sales and operations, such as changes in regulatory requirements, wide-spread viruses and epidemics like the latest novel coronavirus pandemic, which adversely affected our results of operations, or fluctuations in currency exchange rates; and risks related to our principal location in Israel and our status as a Cayman Islands company.

While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed under the heading "Risk Factors" in our most latest Annual Report on Form 20-F, in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot ensure that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, to conform these statements to actual results or to changes in our expectations.

Logo: http://mma.prnewswire.com/media/585787/Sapiens_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/hdi-global-specialty-se-selects-sapiens-for-complete-pc-core-transformation-301686105.html

SOURCE Sapiens International Corporation

Tue, 22 Nov 2022 22:49:00 -0600 en-US text/html https://insurancenewsnet.com/oarticle/hdi-global-specialty-se-selects-sapiens-for-complete-pc-core-transformation
HD0-200 exam dump and training guide direct download
Training Exams List